Gradientech Wins Prestigious Red Dot Design Award

The diagnostics company Gradientech today reveals that its new CU™ product that comes with its already award-winning QuickMIC® system has received the prestigious Red Dot Design Award: Product Design 2025.

The Red Dot label has become one of the most coveted symbols of excellence in design worldwide. Awarded by a jury of 40 international experts, it recognises outstanding products that excel in four key principles for good design: functionality, usability, aesthetic appeal, and sustainability.

“At Gradientech, exceptional product design is a core focus that drives every product development project we undertake. We believe that great design is key to a product’s success on the market, and it serves as an important extension of the Gradientech brand identity,” says Sara Thorslund, CEO and co-founder of Gradientech. “Winning the Red Dot is a mark of excellent innovation and quality and we are truly honoured to receive this award now also for our new CU product.”

The QuickMIC system offers a cutting-edge solution for susceptibility testing bacteria in the blood of sepsis patients, providing results in hours instead of days – crucial for improving patient outcomes in the face of rising antibiotic resistance. Building on the award-winning QuickMIC design, its new CU control unit integrates an intuitive screen and barcode reading solution, further minimising the footprint and optimising valuable bench space in busy clinical labs.

For further information, please contact:
Sara Thorslund, PhD, CEO 
Tel: +46 736 29 35 80 

About Gradientech

Gradientech is a leader in ultra-rapid antibiotic susceptibility testing, developing next-generation diagnostics for infectious disease medicine. Our product QuickMIC®, classified as a breakthrough device by the U.S. Food and Drug Administration, contributes to the effective management of sepsis patients by supporting antibiotic treatment decisions in record time. This helps save lives, reduce healthcare costs, and combat the spread of antibiotic resistance – one of our greatest global health threats. Gradientech is headquartered in Uppsala, Sweden. Visit www.gradientech.se for more information.